Question 1

What are the most cited papers from NZOZ Medi-Spatz?

Accepted Answer

The most cited paper from NZOZ Medi-Spatz is "Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures" (Steve S. Chung, Jacqueline A. French, Jacek Kowalski et al., 2020), with 249 citations. Next come "Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study" (149) and "Intraarticular Injection of a Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial" (82).

Question 2

Which research topics does NZOZ Medi-Spatz publish most on?

Accepted Answer

By volume in 2022-now: Testicular diseases and treatments, Primary Care and Health Outcomes, Psoriasis: Treatment and Pathogenesis and Acne and Rosacea Treatments and Effects.

Question 3

Which fields of science does NZOZ Medi-Spatz work in?

Accepted Answer

In all years, 72% of research at NZOZ Medi-Spatz is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (62%), Health Professions (8%), Neuroscience (7%). It does 1.6× the world's share of Health Sciences.

Question 4

Is NZOZ Medi-Spatz's research output growing?

Accepted Answer

Output in 2022-2025 was 62% higher than in 2018-2021.